摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Cu(2,2′-bipyridine)(NO3)2 | 1241663-28-4

中文名称
——
中文别名
——
英文名称
Cu(2,2′-bipyridine)(NO3)2
英文别名
(2,2'-Bipyridine-kappa^2^N,N')bis(nitrato-kappa^2^O,O')copper(II);copper;2-pyridin-2-ylpyridine;dinitrate
Cu(2,2′-bipyridine)(NO<sub>3</sub>)<sub>2</sub>化学式
CAS
1241663-28-4
化学式
C10H8CuN4O6
mdl
——
分子量
343.743
InChiKey
UJCFXDRMHRDMMP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.66
  • 重原子数:
    21
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    152
  • 氢给体数:
    0
  • 氢受体数:
    8

反应信息

  • 作为反应物:
    描述:
    sodium hydroxide 、 Cu(2,2′-bipyridine)(NO3)2甲醇 为溶剂, 以80.7%的产率得到(2,2'-bipyridine)(O2NO)Cu(μ-OH)2Cu(ONO2)(2,2'-bipyridine)
    参考文献:
    名称:
    The chemistry of dinitrato-2, 2′-bipyridinecopper(II): preparation and characterization of binuclear complexes having a Cu(μ-OH)2Cu and Cu(μ-N3)2Cu core
    摘要:
    The mononuclear Cu(II) complex (bipy)Cu(O2NO)(ONO2) (1) has been obtained by the reaction of bipyridine (bipy) with Cu(NO2)(2).3H2O in methanol solution. 1 reacts with anionic ligands OH- and N-3(-) in methanolic solution to form the stable binuclear complexes (bipy)(O3N)Cu(mu-OH)(2)Cu(NO3) (bipy) (2) and (bipy)(O3N)Cu(mu-N-3)(2)Cu(NO3)(bipy) (3). Complexes 1-3 were characterized including X-ray crystallographic analyses. 1: triclinic P-l with a = 7.9659(4), b = 7.9963(4), c = 10.7860(6) Angstrom, alpha = 81.5070(10), beta = 86.6530( 10), gamma = 63.2120( 10)degrees, V = 606.56(5) Angstrom(3), Z = 2, R = 0.040; 2: triclinic P-1 with a = 7.6167(3), b = 8.4889(3), c=9.8989(3) Angstrom, alpha = 110.583(12), beta = 108.866(15), gamma = 97.802(11)degrees, V = 544.05(3) Angstrom(3), Z = 1, R = 0.042;3: monoclinic with a = 6.8101 (3), b = 17.5101(8), c = 10.5084(5) Angstrom, beta = 98.2940( 10)degrees, V = 1239.97( 10) Angstrom(3), Z = 4, R = 0.029. 1 has a monodentate and a semi-bidentate nitrate ligand and is structurally related to (bipy)Cu(NO2)(2) rather than to its silver analog, (bipy)Ag(NO3)(2), which forms a polymeric chain. Complexes 2 and 3 are dimeric in nature and possess bridging OH- and N-3(-) ligands, respectively. (C) 1998 Elsevier Science S.A. All rights reserved.
    DOI:
    10.1016/s0020-1693(98)00007-3
  • 作为产物:
    描述:
    2,2'-联吡啶copper(II) nitrate trihydrate乙醇 为溶剂, 以90%的产率得到Cu(2,2′-bipyridine)(NO3)2
    参考文献:
    名称:
    具有混合配体的铜 (II) 和镍 (II) 的 1D 之字形配位聚合物 - 合成和结构
    摘要:
    一维配位聚合物 [Cu(NO3)2(2,2'-bipy)(4,4'-bipy)]n·2nCH3OH (1) 和 [Ni(tren)(4,4'-bipy)] n(ClO4)2n (2) 是通过 2,2'-bipy 的铜 (II) 配合物和 tren 与 4,4'-bipy 的镍 (II) 配合物的自组装合成的 (2, 2'-bipy = 2,2'-联吡啶,4,4'-bipy = 4,4'-联吡啶,tren = 三-(2-氨基乙基)胺)。他们的 X 射线晶体结构表明,1 和 2 中的金属离子显示出扭曲的八面体配位几何结构,以在顺式位置结合两个 4,4'-双联配体。每个 4,4'-bipy 将 1 中的两个 [Cu(NO3)2(2,2'-bipy)] 单元和 2 中的两个 [Ni(tren)]2+ 单元连接起来,形成一维锯齿形链。在 1 的结构中,这些链通过 2,2'-bipy 配体通过偏移 π−π
    DOI:
    10.1002/1099-0682(200111)2001:11<2857::aid-ejic2857>3.0.co;2-3
  • 作为试剂:
    描述:
    (E)-1-(1-methyl-1H-imidazol-2-yl)-3-phenylprop-2-en-1-one丙二酸二甲酯sodium nitrateCu(2,2′-bipyridine)(NO3)2 作用下, 以 丙醇乙腈 为溶剂, 反应 72.0h, 以87.6%的产率得到
    参考文献:
    名称:
    基于DNA的不对称催化:离子溶剂和甘醇二甲醚的作用。
    摘要:
    最近,DNA被评估为金属络合物的手性支架,可构建所谓的“基于DNA的杂化催化剂”,它是酶的强大而廉价的替代品。DNA的独特手性结构使杂化催化剂能够催化各种不对称合成反应。然而,当前大多数研究使用水性缓冲液作为这些不对称反应的溶剂,其中底物/产物通常悬浮在溶液中。传质限制通常需要较长的反应时间。为了克服这一障碍并推进基于DNA的不对称催化,我们评估了一系列离子液体(ILs),无机盐,深共熔溶剂(DES),甘醇二甲醚,乙二醇,乙腈和甲醇作为DNA的助溶剂/添加剂基于非对称迈克尔加成。一般来说,这些添加剂可诱导圆二色性(CD)光谱表明DNA B形式的双链体构象无明显变化,但会对基于DNA的杂化催化剂的催化效率产生重大影响。传统的有机溶剂(例如乙腈和甲醇)导致产品收率低和/或对映选择性低。除了0.2 M [BMIM] [CF3COO](95.4%ee和93%的收率)和0.2M [BMIM] Cl(93
    DOI:
    10.1039/c4ra10749g
点击查看最新优质反应信息

文献信息

  • Two air oxidation copper(II) complexes of salicylaldehyde derivatives obtained by in situ copper(II) ion catalysis and complexation
    作者:Geng Jiao、Tao Tao、Gu Ke-Hua、Wang Gang、Huang Wei
    DOI:10.1016/j.inoche.2011.09.025
    日期:2011.12
    Abstract A new salicylaldehyde derivative 1, i.e. 5-chloro-3-(ethoxymethyl)-2-hydroxybenzaldehyde, has been prepared and structurally characterized. A novel dinuclear copper(II) complex of its air-oxidized product 2 has been successfully yielded from the in situ copper(II) ion catalysis and complexation. Additionally, another control experiment has been carried out by using 3,5-dibromo-2-hydroxybenzaldehyde
    摘要 制备了一种新的水杨醛生物1,即5--3-(乙氧基甲基)-2-羟基苯甲醛并对其进行了结构表征。其空气氧化产物 2 的新型双核 (II) 配合物已通过原位 (II) 离子催化和络合成功获得。另外,以3,5-二-2-羟基苯甲醛为原料进行了另一对照实验,得到了类似的单核空气氧化铜(II)配合物3,其中3,5-二-2-羟基苯甲醛也被原位转化为 3,5-二溴-2-羟基苯甲酸的二价阴离子。
  • One-Dimensional Self-assembled Coordination Polymer, {[Cu(bpy)(bpe)(NO3)2]·(H2O)4}n
    作者:Vitthal A. Kawade、Satish S. Bhat、Ray J. Butcher
    DOI:10.1007/s10870-019-00782-9
    日期:2019.12
    Coordination polymer [Cu(bpy)(bpe)(NO3)2]·(H2O)4}n (CP1) has been synthesized using [Cu(bpy)(NO3)2] (where bpy = 2,2′-bipyridine) and bpe (bpe = 1,2-bis(4-pyridyl)ethane as a spacer in equimolar ratio. CP1 was characterized by using Infrared spectroscopy, elemental analysis, and single crystal X-ray diffraction. The crystal structure confirms that the CP1 is formed with a bridging bpe linker giving
    已使用 [Cu(bpy)(NO3)2] 合成配位聚合物 [Cu(bpy)(bpe)( )2]·(H2O)4}n (CP1)(其中 bpy = 2,2'-联吡啶) 和 bpe (bpe = 1,2-双 (4-吡啶基) 乙烷作为等摩尔比的间隔物。使用红外光谱、元素分析和单晶 X 射线衍射表征了 CP1。晶体结构证实了 CP1由桥接 bpe 接头形成,在一维 (1D) 结构中产生螺旋链。离子与 bpy 中的两个氮原子、硝酸根阴离子(主要成分)中的两个氧原子和两个 bpe 配体中的两个氮原子相连. 还有一个额外的次要成分,它是五个坐标。氢键连接螺旋链以生成三维 (3D) 网络结构。图形摘要A一维配位聚合物[(Cu(bpy)(bpe)( )2]· )4}n (CP1)已使用[Cu(bpy)( )2]合成(其中bpy = 2 ,2'-联吡啶)作为结构单元,bpe(bpe = 1,
  • Dinuclear copper(II) complexes bridged with acetate and nitrate anions: Study of protein binding and in-vitro anticancer activity
    作者:Sabiha A. Shaikh、Satish S. Bhat、Vidyanand K. Revankar、S. Naveen、Mahesha、N.K. Lokanath、Vijay Kumbar
    DOI:10.1016/j.ica.2023.121799
    日期:2024.1
    geometry around both the copper(Ⅱ) centers. Complex 2 consists of two copper(Ⅱ) centers with two bridging nitrates via oxygen atoms in a distorted square pyramidal environment. The complexes 1 and 2 efficiently bind to BSA (bovine serum albumin) showing a dynamic quenching mechanism. The in-vitro anticancer activity have been investigated against HeLa cell lines using MTT assay. Complex 1 is two times more
    两个双核(Ⅱ)配合物[Cu(L)(μ-AcO) 2 ] 2 ·H 2 O ( 1 )和[Cu(L)(bpy)(μ-NO 3 )] 2。(ClO 4 ) 2 ( 2 ) 用配体 L = N-(3-吡啶基)-1,8-二甲酰亚胺(其中,OAc = 乙酸盐,bpy = 2,2'-联吡啶)合成。采用 FT-IR、UV-vis、荧光、EPR 和单晶 X 射线衍射技术对配合物进行了表征。配合物1包含两个(II)单元,四个乙酸根离子通过氧原子桥接,在两个(II)中心周围具有扭曲的四角锥体几何形状。综合体2由两个(Ⅱ)中心和两个通过氧原子桥接的硝酸盐在扭曲的方锥体环境中组成。复合物1和2有效结合 BSA牛血清白蛋白),显示出动态猝灭机制。使用 MTT 测定对 HeLa 细胞系进行了体外抗癌活性研究。在相同的实验条件下,复合物1的活性是顺铂的两倍,而复合物2 的活性是顺铂的十二倍。
  • Spectroscopic and electrochemical studies of hetero–bimetallic copper complexes with Schiff's base ligand
    作者:S. Deepalatha、P. Sambasiva Rao、R. Venkatesan
    DOI:10.1016/j.saa.2005.08.010
    日期:2006.7
    Using Schiff's base ligand, several Cu(II) based bimetallic complexes such as Cu-Cu, Cu-Co, Cu-Ni. Cu-Zn, Cu-Mn have been prepared in a stepwise procedure. The structures of these complexes and the ligand have been proposed on the basis of FAB mass, elemental analysis, UV-vis, IR, electron paramagnetic resonance (EPR) and CV studies. EPR parameters. obtained through complete simulation, suggest that the formation of bimetallic complexes forces the Cu(II) centre to increase the flexibility in comparison with the monometallic Cu(II) complex. However, the nature of the second metal ion in the bimetallic complex effects the distortion around the first metal ion. The reduction of the complexes from Cu(II) to Cu(I) involves a large geometrical change and is found to be irreversible. A large positive shift is seen in the cathodic process, which can be ascribed to increased distortion due to bimetallic coordination. These complexes have potential usage in DNA studies. (c) 2005 Published by Elsevier B.V.
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)